Takeda gets Japanese antitrust regulators' blessing for Shire deal; France's Acticor Biotech raises €15.3M for stroke drug
→ Takeda has cleared another hurdle for the Shire buyout that would make it one of the world’s 10 biggest pharma companies. The fair trade …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
